Alternative title: Immunoglobulin, Blood products

Live-attenuated vaccines such as measles-mumps-rubella (MMR), measles-mumps-rubella-varicella (MMRV), varicella (chickenpox) or zoster (shingles) vaccination may be affected by circulating antibodies in immunoglobulin therapy or blood products. This includes normal human immunoglobulin therapy for conditions like Kawasaki’s disease or a blood transfusion for treatment of a medical condition.

There have been guidelines developed that outline the recommended intervals between either immunoglobulins or blood products and these live attenuated vaccines.(see resource link below)

Note that inactivated (non-live) vaccines can be safely administered following immunoglobulins or blood products.

Resources

The Immunisation Handbook 10th edition table 3.3.6 has recommended intervals between either immunoglobulins or blood products and MMR, MMRV, varicella or zoster vaccination.

 

Reviewed by: Georgina Lewis – Clinical manager and Nigel Crawford (Paediatrician, The Royal Children’s Hospital, Melbourne)
Date: November 2016
Materials in this section are updated as new information and vaccines become available. The Melbourne Vaccine Education Centre (MVEC) staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family’s personal health. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult a healthcare professional.


RCH
Monash
Melbourne University
SAEFVIC

Welcome to MVEC

The Melbourne Vaccine Education Centre (MVEC) is a new web-based initiative, providing up-to-date immunisation information for healthcare professionals, parents and the public.

It is a collaboration between The Royal Children’s Hospital (RCH) and its Melbourne Children’s campus partners (Murdoch Children's Research Institute and The University of Melbourne) and Monash Health.

MVEC aims to address common queries around vaccines and to promote the benefits of immunisation for both children and adults.